Project Abstract
Spine defects and synaptic dysfunction are common to neurodevelopmental disorders characterized by
cognitive impairments in language, learning and sensory processing. Angelman Syndrome (AS) is a
disorder caused by mutation of the maternal Ube3a allele, resulting in neuronal loss of the encoded
ubiquitin ligase via developmental paternal imprinting. Delayed milestones are evident at 6-12 months of
age, with progression to seizures and autistic features that include impaired speech, intellectual disability,
altered social behaviors, and aberrant responses to sensory stimuli, including aversions to certain odors,
flavors and textures. AS pathogenesis is not well understood; Ube3a participates in multiple cellular
processes, including turnover of synaptic proteins. Spine defects, impaired synaptic plasticity, and deficits
in cortical inhibitory drive are found in adult and juvenile AS mouse models, however it is not known how
Ube3a loss impacts early stages of neuronal maturation and circuit integration. Gene reinstatement has
established an early requirement for Ube3a in which the critical window for full phenotypic rescue occurs
during prenatal/neonatal development, and we hypothesize that pathogenesis begins at this time, while
newly-imprinted neurons are still maturing and engaged in circuit assembly. Intriguingly, selective loss of
Ube3a in GABAergic interneurons reproduces features of circuit dysfunction caused by pan-neuronal loss,
highlighting GABAergic neurons potential therapeutic targets. Adult-born interneurons that integrate in the
adult olfactory bulb (OB) are subject to the same mutation effects as those born in embryo. In our work,
we found that while Ube3a is absent in most brain regions in AS mice, the adult olfactory system shows a
pattern of Ube3a expression that allows us to monitor paternal imprinting as new GABAergic granule cells
(GCs) are generated, migrate, and mature in the OB. Moreover, we find that new, 35 day-old GCs show
spine abnormalities. In this exploratory work, we propose to test the hypothesis that imprinting-mediated
loss of Ube3a disrupts subsequent GC maturation, and that as a consequence, spine development is
impaired. Study aims will test this by defining a precise temporal profile of paternal imprinting in birth-
dated GCs, and cell reconstruction/quantitative morphological analyses will identify emerging structural
abnormalities relative to the timing of Ube3 loss. How the mutation affects olfaction is unknown, and in the
final aim we will use a modified social interaction test to evaluate innate responses to conspecific odors.
The overall goal of this project is to identify developmental defects that emerge from Ube3a loss in GCs to
gain an understanding of both its normal role in GC maturation, and interneuron pathobiology in AS.